The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
<p>Abstract</p> <p>Hypertrophic cardiomyopathy (HCM) is the most common genetic disease of the heart. HCM is characterized by a wide range of clinical expression, ranging from asymptomatic mutation carriers to sudden cardiac death as the first manifestation of the disease. Over 100...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2012-02-01
|
| Series: | Journal of Cardiovascular Magnetic Resonance |
| Online Access: | http://www.jcmr-online.com/content/14/1/17 |
| _version_ | 1827279579812724736 |
|---|---|
| author | Noureldin Radwa A Liu Songtao Nacif Marcelo S Judge Daniel P Halushka Marc K Abraham Theodore P Ho Carolyn Bluemke David A |
| author_facet | Noureldin Radwa A Liu Songtao Nacif Marcelo S Judge Daniel P Halushka Marc K Abraham Theodore P Ho Carolyn Bluemke David A |
| author_sort | Noureldin Radwa A |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Hypertrophic cardiomyopathy (HCM) is the most common genetic disease of the heart. HCM is characterized by a wide range of clinical expression, ranging from asymptomatic mutation carriers to sudden cardiac death as the first manifestation of the disease. Over 1000 mutations have been identified, classically in genes encoding sarcomeric proteins. Noninvasive imaging is central to the diagnosis of HCM and cardiovascular magnetic resonance (CMR) is increasingly used to characterize morphologic, functional and tissue abnormalities associated with HCM. The purpose of this review is to provide an overview of the clinical, pathological and imaging features relevant to understanding the diagnosis of HCM. The early and overt phenotypic expression of disease that may be identified by CMR is reviewed. Diastolic dysfunction may be an early marker of the disease, present in mutation carriers prior to the development of left ventricular hypertrophy (LVH). Late gadolinium enhancement by CMR is present in approximately 60% of HCM patients with LVH and may provide novel information regarding risk stratification in HCM. It is likely that integrating genetic advances with enhanced phenotypic characterization of HCM with novel CMR techniques will importantly improve our understanding of this complex disease.</p> |
| first_indexed | 2024-04-24T08:21:19Z |
| format | Article |
| id | doaj.art-4a0eab178ea2475f8cb5771fda522b81 |
| institution | Directory Open Access Journal |
| issn | 1097-6647 1532-429X |
| language | English |
| last_indexed | 2024-04-24T08:21:19Z |
| publishDate | 2012-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Cardiovascular Magnetic Resonance |
| spelling | doaj.art-4a0eab178ea2475f8cb5771fda522b812024-04-17T00:49:34ZengElsevierJournal of Cardiovascular Magnetic Resonance1097-66471532-429X2012-02-011411710.1186/1532-429X-14-17The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonanceNoureldin Radwa ALiu SongtaoNacif Marcelo SJudge Daniel PHalushka Marc KAbraham Theodore PHo CarolynBluemke David A<p>Abstract</p> <p>Hypertrophic cardiomyopathy (HCM) is the most common genetic disease of the heart. HCM is characterized by a wide range of clinical expression, ranging from asymptomatic mutation carriers to sudden cardiac death as the first manifestation of the disease. Over 1000 mutations have been identified, classically in genes encoding sarcomeric proteins. Noninvasive imaging is central to the diagnosis of HCM and cardiovascular magnetic resonance (CMR) is increasingly used to characterize morphologic, functional and tissue abnormalities associated with HCM. The purpose of this review is to provide an overview of the clinical, pathological and imaging features relevant to understanding the diagnosis of HCM. The early and overt phenotypic expression of disease that may be identified by CMR is reviewed. Diastolic dysfunction may be an early marker of the disease, present in mutation carriers prior to the development of left ventricular hypertrophy (LVH). Late gadolinium enhancement by CMR is present in approximately 60% of HCM patients with LVH and may provide novel information regarding risk stratification in HCM. It is likely that integrating genetic advances with enhanced phenotypic characterization of HCM with novel CMR techniques will importantly improve our understanding of this complex disease.</p>http://www.jcmr-online.com/content/14/1/17 |
| spellingShingle | Noureldin Radwa A Liu Songtao Nacif Marcelo S Judge Daniel P Halushka Marc K Abraham Theodore P Ho Carolyn Bluemke David A The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance Journal of Cardiovascular Magnetic Resonance |
| title | The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance |
| title_full | The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance |
| title_fullStr | The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance |
| title_full_unstemmed | The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance |
| title_short | The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance |
| title_sort | diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance |
| url | http://www.jcmr-online.com/content/14/1/17 |
| work_keys_str_mv | AT noureldinradwaa thediagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT liusongtao thediagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT nacifmarcelos thediagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT judgedanielp thediagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT halushkamarck thediagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT abrahamtheodorep thediagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT hocarolyn thediagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT bluemkedavida thediagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT noureldinradwaa diagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT liusongtao diagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT nacifmarcelos diagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT judgedanielp diagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT halushkamarck diagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT abrahamtheodorep diagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT hocarolyn diagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance AT bluemkedavida diagnosisofhypertrophiccardiomyopathybycardiovascularmagneticresonance |